Contact this trialFirst, we need to learn more about you.
FAK Inhibitor
Defactinib for Cancer with NF2 Mutations
Recruiting1 awardPhase 2
Philadelphia, Pennsylvania
This trial is testing defactinib to see if it can shrink or stop the growth of cancer in patients with NF2 mutations.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.